Associations of clinical features of functional bowel disorders with gut microbiota characteristics in adolescents: A pilot study

Background. Obesity is a multifactorial disease that is one of the important public health problems in the 21st century. Functional bowel disorders in obese children and adolescents are one of the most common pathologies of the digestive tract.
The aim: to characterize the bacteriological composition of the colon microbiota in obese adolescents and identify its associations with the clinical manifestations of functional bowel disorders.
Materials and methods. The study included 20 adolescents aged 11–17 years. Stool consistency was assessed using the Bristol Stool Scale. The study of biological material was carried out using standard bacteriological methods. To assess the strength of the relationship between the nominal variables, Cramer’s V test was used.
Results. It has been shown that in adolescents with obesity and functional bowel disorders, there is a decrease in the number of representatives of bifidoflora, an increase in the microbial density of Escherichia coli with altered enzymatic properties and an excessive growth of potentially pathogenic enterobacteria. In obese adolescents with functional bowel disorders, abdominal pain associated with the act of defecation is associated with the presence of enterobacteria and E. coli with altered enzymatic properties. Rare bowel movements are associated with an increased abundance of Enterococcus spp. and the presence of opportunistic Enterobacteriaceae microorganisms. Frequent bowel movements are associated with the presence of E. coli with altered enzymatic properties and Clostridium spp. In the presence of loose stool, Clostridium spp. is present; unstable stool (alternation of hard and liquid stools in one patient) is associated with a decrease in the number of lactobacilli and E. coli with normal enzymatic properties, the appearance of E. coli with altered enzymatic properties, opportunistic microorganisms of Enterobacteriaceae family and Clostridium spp.
Conclusion. The relationship between the clinical symptoms of functional bowel disorders and changes in the composition of the gut microbiota in obese adolescents may be a justification for conducting in-depth studies aimed at finding early predictors of functional bowel diseases associated with obesity in the adult cohort.

1. World Health Organization. Tenfold increase in childhood and adolescent obesity in four decades: New study by Imperial College London and WHO. URL: https://www.who.int/ru/news/item/11-10-2017-tenfold-increase-in-childhood-and-adolescent-obesityin-four-decades-new-study-by-imperial-college-london-and-who [date of access: 11.11.2021].

2. Pogodina A, Romanitsa A, Rychkova L. Functional bowel disorders and obesity in children: State of the problem. International Journal of Biomedicine. 2020; 10(4): 316-323. doi: 10.21103/Article10(4)_RA2

3. Boulange CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016; 8(1): 42. doi: 10.1186/s13073-016-0303-2

4. Tambucci R, Quitadamo P, Ambrosi M, De Angelis P, Angelino G, Stagi S, et al.Association between obesity/overweight and functional gastrointestinal disorders in children. J Pediatr Gastroenterol Nutr. 2019; 68(4): 517-520. doi: 10.1097/MPG.0000000000002208

5. Zhao L. The gut microbiota and obesity: From correlation to causality. Nat Rev Microbiol. 2013; 11(9): 639-647. doi: 10.1038/nrmicro3089

6. Pogodina AA, Romanitsa AI, Rychkova LV. Obesity and functional bowel disorders: Are they linked? Obesity and Metabolism. 2021; 18(2): 132-141. (In Russ.). doi: 10.14341/omet12706

7. Nemchenko UM, Savelkaeva MV, Grigorova EV, Ivanova EI, Pogodina AV, Rychkova LV. Comparison of microecological intestinal indices in children with different value of body mass index. Acta biomedica scientifica. 2017; 2(5-1): 111-115. (In Russ.). doi: 10.12737/article_59e85bd5a2a419.21754916

8. Shankar V, Agans R, Holmes B, Raymer M, Paliy O. Do gut microbial communities differ in pediatric IBS and health? Gut Microbes. 2013; 4(4): 347-352. doi: 10.4161/gmic.24827

9. Del PM, Carmagnola S, Anderloni A, Andorno S, Ballare M, Balzarini M, et al. The use of probiotics in healthy volunteers with evacuation disorders and hard stools: A double-blind, randomized, placebo-controlled study. J Clin Gastroenterol. 2010; 44(Suppl 1): S30-S34. doi: 10.1097/MCG.0b013e3181ee31c3

10. Simrén M, Barbara G, Flint HJ, Spiegel BMR, Spiller RC, Vanner S, et al. Intestinal microbiota in functional bowel disorders: A Rome foundation report. Gut. 2013; 62(1): 159-176. doi: 10.1136/gutjnl-2012-302167

11. Drossman DA. Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016; 150(6): 1262-1279. doi: 10.1053/j.gastro.2016.02.032

12. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, Tilburg M. Functional disorders: Children and adolescents. Gastroenterology. 2016; 150(6): 1456-1468. doi: 10.1053/j.gastro.2016.02.015

13. Grigorova EV, Belkova NL, Nemchenko UM, Klimenko ES, Pogodina AV, Romanitsa AI, et al. Metasequencing of V3–V4 variable regions of 16S rRNA gene in opportunistic microbiota and gut biocenosis in obese adolescents. Bull Exp Biol Med. 2021; 170(3): 321-325. doi: 10.1007/s10517-021-05060-3

14. Belmer SV, Razumovsky AYu, Khavkin AI. Bowel diseases in children. Moscow: Publishing House “Medpraktika-M”; 2018. (In Russ.).

15. Kim MY, Choi SW. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutr Res Pract. 2021; 15(4): 411-430. doi: 10.4162/nrp.2021.15.4.411

16. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997; 32(9): 920-924. doi: 10.3109/00365529709011203

17. Menshikov VV. Clinical laboratory research techniques: A reference guide. Vol. 3. Clinical Microbiology. Moscow: Labora; 2009. (In Russ.)

18. Pozuelo M, Pand S, Santiago A, Mendez S, Accarino A, Santos J, et al. Reduction of butyrate-and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep. 2015; 5: 12693. doi: 10.1038/srep12693

19. Kopanev YuA, Sokolov AL. Intestinal dysbiosis: Microbiological, immunological, clinical, microecological aspects. Moscow: Litagent Ridero; 2002. (In Russ.).

20. Letzel H, Herget HF. Management of symbiosis (treatment of patients with dysbiosis). Moscow; 2009. (In Russ.)

21. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341(6150): 1241214. doi: 10.1126/science.1241214

22. Zhao Y, Yu YB. Intestinal microbiota and chronic constipation. Springerplus. 2016; 5(1): 1130. doi: 10.1186/s40064-016-2821-1

23. Pimentel M, Gunsalus RP, Rao SS, Zhang H. Methanogens in human health and disease. Am J Gastroenterol Suppl. 2012; 1: 28-33. doi: 10.1038/ajgsup.2012.6

24. Fábrega VL, Ferreira AJ, Patricio FR, Brinkley S, Skalecki IC. Cell-detaching Escherichia coli (CDEC) strains from children with diarrhea: Identification of a protein with toxigenic activity. FEMS Microbiol Lett. 2002; 217(2): 191-197. doi: 10.1016/S0378-1097(02)01071-6

25. Ivanov II, Littman DR. Segmented filamentous bacteria take the stage. Mucosal Immunol. 2010; 3(3): 209-212. doi: 10.1038/mi.2010.3

26. Carco C, Young W, Gearry RB, Talley NJ, McNabb WC, Roy NC. Increasing evidence that irritable bowel syndrome and functional gastrointestinal disorders have a microbial pathogenesis. Front Cell Infect Microbiol. 2020; 10: 468. doi: 10.3389/fcimb.2020.00468

27. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis. 2009; 41(12): 850-853. doi: 10.1016/j.dld.2009.07.023

28. Pogodina AV, Romanitsa AI, Rychkova LV. Obesity and functional bowel disorders in children. Pediatr. 2021; 12(1): 59-69. (In Russ.). doi: 10.17816/PED12159-69